PMV Pharmaceuticals's total assets for Q4 2024 were $191.29M, a decrease of -14.41% from the previous quarter. PMVP total liabilities were $15.21M for the fiscal quarter, a -40.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.